3D Bioprinting Market
3D Bioprinting Market Size, Share and Industry Analysis Report By Component (3D Bioprinters and Bio ink); By Technology (Magnetic Levitation and Inkjet-based); By Material Type (Living Cells, Hydrogels, Extracellular Matrices);By Application (Dental, Biosensors, Medical Research and Clinical); By End user (Biopharma, Academia, Research Organizations and Hospitals) - Forecast Year 2024 – 2031
Healthcare // Biotechnology
Market Definition
What is 3D Bioprinting?
Key Market Trends
Enriching the use of 3D
bioprinting in pharmaceutical and cosmetology industries
Many pharmaceutical companies are integrating 3D bioprinting products
and technologies into drug discovery and development. Compared to traditional
drug testing methods, 3D bioprinting allows pharmaceutical companies to test
drugs more safely and at a lower cost. The conventional drug discovery process
takes three to six years, whereas 3D bioprinting enables pharmaceutical
companies to test a drug in a matter of hours. 3D bioprinted tissues also allow
research and development teams to test new drugs in the early stages and during
preclinical trials. The benefits of 3D bioprinting include reduced use of
animals for drug testing, increased productivity, and a shorter drug discovery
process.
The Asia Pacific Region Is
Projected To Grow At The Highest CAGR During The Forecast Period
The Asia Pacific region is predicted to experience the most significant
CAGR growth for the bone and joint health supplements market. The increasing
prevalence of chronic respiratory and cardiovascular disorders (CVDs) due to
the aging population, the rising requirement for regenerative medicines/cancer
therapeutics/stem cell solutions, the increasing government and private
funding, and technological advancements such as the development of AI and
organ-on-a-chip.
Regional Outlook (Revenue, USD Million; 2022
& 2030)
|
Regional Outlook
(Revenue, USD Million; 2020-2030) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East & Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 1 3D Bioprinting Market: Regional
Dynamics
An exclusive 3D
Bioprinting market research report provides an in-depth analysis of the market
dynamics across five regions: North America, Europe, South America,
Asia-Pacific, Middle East, and Africa. Furthermore, the market has been
evaluated by utilizing diverse research methodologies and internal statistical model.
Companies Considered And Profiled In This
Market Study
The players
operating in the market have undertaken several strategies related to the
market in the period 2020-2022. some of the prominent players in the 3D
Bioprinting market include
· 3D bio Therapeutics
· Advanced Solutions
Life Sciences, LLC
· Allevi, Inc. (Part
Of 3D Systems, Inc.)
· Aspect Biosystems
Ltd.
· Bico Group AB
· Brinter
· Collplant
Biotechnologies Ltd.
· Cyfuse Biomedical
K.K.
· Envisiontec Gmbh
(Part Of Desktop Metal, Inc.)
· Foldink Life
Science Technologies
· Gesim Mbh
· Manchester Biogel
· Organovo Holdings
Inc.
· Pandorum
Technologies Pvt. Ltd.
· Poietis
· Precise Bio
· Prellis Biologics
· Regemat 3D
· Regenhu
· Regenovo
Biotechnology Co., Ltd. (Part Of Shining 3D Tech Co., Ltd.)
· Revotek Co., Ltd.
· Rokit Healthcare,
Inc.
· Sunp Biotech, Llc
· Tissue Regeneration
Systems Inc.
· Vivax Bio, Llc
Recent Developments
In May 2022, BICO
Group AB acquired Allegro 3D Inc., based in San Diego, California, USA, further
strengthen the Bioprinting business area’s position as a global market leader
in 3D bioprinting.
In September 2022, 3D
Systems announced the formation of a new, wholly owned company called Systemic
Bio, a biotech company focused on the application of advanced bioprinting
technologies to pharmaceutical drug discovery and development.
In November 2022, CollPlant
announced the Company is launching Collink.3D 90, a recombinant human collagen
(rhCollagen)-based bioink for use in a variety of 3D bioprinting applications.
Global 3D Bioprinting Market Report Scope
|
Historical
data |
2020 - 2021 |
|
Base
year for estimation |
2022 |
|
Forecast
period |
2023 - 2030 |
|
Market
size value in 2022 |
USD XX Billion |
|
Revenue
forecast in 2030 |
5.79 Billion |
|
Growth
Rate |
CAGR of 22.4%
from 2022 to 2030 |
|
Quantitative
units |
Revenue in USD Million/Billion & CAGR
from 2022 to 2030 |
|
Report
coverage |
Revenue
forecast, company share, competitive landscape, growth factors, and trends |
|
Segments
covered |
Component Type, Technology, Material Type,
Application, End user |
|
Key
companies profiled |
Bico Group
Ab, Organovo Holdings Inc., Allevi, Inc. (Part Of 3D Systems, Inc.), Collplant
Biotechnologies Ltd. |
|
Regional
Scope |
North America, Europe, Asia Pacific, Middle
East & Africa, Latin America |
|
Country
Scope |
U.S.,
Canada, Germany, U.K., France, Italy, Spain, India, Japan, China, Australia,
South Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina |
|
Customization
scope |
Free report customization (equivalent to up
to 8 analysts’ working days) with purchase. Addition or alteration to
country, regional & segment scope. |
Component Type Outlook (Revenue, USD
Million/Billion; 2019-2030)
· 3D Bioprinters
· Bioinks
o Natural Bioinks
o Hybrid Bioinks
o Synthetic Bioinks
Technology Outlook (Revenue, USD
Million/Billion; 2019-2030)
· Microextrusion
bioprinting
· Inkjet 3D
bioprinting
· Laser-assisted
bioprinting
· Stereolithography-based
bioprinting
· Magnetic 3D
bioprinting
· Other Technologies
Material Type Outlook (Revenue, USD
Million/Billion; 2019-2030)
· Living Cells
· Hydrogels
· Extracellular
Matrices
· Other Biomaterials
Application Outlook (Revenue, USD
Million/Billion; 2019-2030)
· Research
applications
o Drug Research
o Regenerative
Medicine
o 3D Cell Culture
· Clinical
applications
o Skin
o Bone And Cartilage
o Blood Vessels
o Other Clinical
Applications
End user Outlook (Revenue, USD
Million/Billion; 2019-2030)
· Research
Organizations and Academic Institutes
· Biopharmaceutical
Companies
· Hospitals
Regional Outlook (Revenue, USD
Million/Billion; 2019-2030)
· North America
o U.S.
o Canada
· Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of the Europe
· Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Rest of
Asia-Pacific
· Middle East &
Africa
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East
& Africa
· Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin
America
|
Chapter
1. Introduction |
|
|
1.1. Market Definition |
|
|
1.2. Research Scope |
|
|
1.2.1. Markets Covered |
|
|
1.2.2. Years Considered for
Study |
|
|
Chapter 2. Executive
Summary |
|
|
2.1. Summary Snapshot Market Size
and Forecast, 2020-2030 |
|
|
2.2. 3D Bioprinting Market Share by
Component Type, 2022 vs 2030 (USD Million) |
|
|
2.3. 3D Bioprinting Market Share by
Technology, 2022 vs 2030 (USD Million) |
|
|
2.4. 3D Bioprinting Market Share by Material Type, 2022 vs 2030 (USD
Million) |
|
|
2.5. 3D Bioprinting Market Share by
Application, 2022 vs 2030 (USD Million) |
|
|
2.5. 3D Bioprinting Market Share by End user,
2022 vs 2030 (USD Million) |
|
|
2.6. 3D Bioprinting Market Share by
Region, 2022 vs 2030 (USD Million) |
|
|
Chapter 3. Key Insights |
|
|
Chapter 4. 3D Bioprinting
Market Segmentation & Impact Analysis |
|
|
4.1. 3D Bioprinting Market Indicators Analysis
|
|
|
4.1.1. Market Drivers
Analysis |
|
|
4.1.1.1. Increasing
use of 3D bioprinting in pharmaceutical and cosmetology industries |
|
|
4.1.1.2. Developments
in 3D bioprinting for tissue and organ regeneration applications |
|
|
4.1.1.3. Rising
public and private funding to support bioprinting research activities |
|
|
4.1.2. Market Restraint
Analysis |
|
|
4.1.2.1. High development and
production costs |
|
|
4.1.2.2. Lack of
regulatory guidelines governing 3D bioprinting |
|
|
4.1.3. Market Opportunity
Analysis |
|
|
4.1.3.1. Rising
demand for organ transplant |
|
|
4.1.3.2. Growing
awareness of 3D bioprinting |
|
|
4.2. Regulatory Analysis |
|
|
4.2.1. North America |
|
|
4.2.1.1. U.S. |
|
|
4.2.1.2. Canada |
|
|
4.2.2. Europe |
|
|
4.2.3. Asia Pacific |
|
|
4.2.3.1. India |
|
|
4.2.3.2. Japan |
|
|
4.2.3.3. China |
|
|
4.3. Technological Insights |
|
|
4.4. COVID-19 Impact analysis on 3D
Bioprinting Market |
|
|
4.5. Porter’s Five Forces Analysis |
|
|
4.5.1. Bargaining Power of
Buyers/Consumers |
|
|
4.5.2. Bargaining Power of
Suppliers |
|
|
4.5.3. Threat of New Entrants |
|
|
4.5.4. Threat of Substitute
Products |
|
|
4.5.5. Intensity of Competitive
Rivalry |
|
|
4.6. Competitive Metric Space Analysis |
|
|
Chapter 5. 3D
Bioprinting Market, By Component Type (Market Size and Forecast by Value -
USD Million, 2020 - 2030) |
|
|
5.1. 3D Bioprinting Market, By
Component Type (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
|
5.1.1. 3D Bioprinters |
|
|
5.1.1.1. 3D Bioprinters Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
5.1.1.2. 3D Bioprinters Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
5.1.2. Bioinks |
|
|
5.1.2.1. Bioinks
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
5.1.2.2. Bioinks Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
5.1.2.3. Natural Bioinks |
|
|
5.1.2.3.1. Natural Bioinks Market Estimates and Forecast, 2020-2030
(USD Million) |
|
|
5.1.2.3.2.
Natural Bioinks Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
5.1.2.4. Hybrid Bioinks |
|
|
5.1.2.4.1. Hybrid Bioinks Market Estimates and Forecast, 2020-2030
(USD Million) |
|
|
5.1.2.4.2. Hybrid Bioinks Market Estimates and Forecast, By Region, 2020-2030
(USD Million) |
|
|
5.1.2.5. Synthetic Bioinks |
|
|
5.1.2.5.1. Synthetic Bioinks
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
5.1.2.5.2. Synthetic Bioinks Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
Chapter 6. 3D
Bioprinting Market, By Technology (Market Size and Forecast by Value - USD
Million, 2020 - 2030) |
|
|
6.1. 3D Bioprinting Market, By
Technology (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
6.1.1. Microextrusion bioprinting |
|
|
6.1.1.1. Microextrusion bioprinting Market Estimates
and Forecast, 2020-2030 (USD Million) |
|
|
6.1.1.2. Microextrusion bioprinting Market Estimates
and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.2. Inkjet 3D bioprinting |
|
|
6.1.2.1. Inkjet 3D bioprinting Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
6.1.2.2. Inkjet 3D bioprinting Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.3. Laser-assisted
bioprinting |
|
|
6.1.3.1.
Laser-assisted bioprinting Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
6.1.3.2.
Laser-assisted bioprinting Market Estimates and Forecast, By Region, 2020-2030
(USD Million) |
|
|
6.1.4. Stereolithography-based
bioprinting |
|
|
6.1.4.1.
Stereolithography-based bioprinting Market Estimates and Forecast, 2020-2030
(USD Million) |
|
|
6.1.4.2.
Stereolithography-based bioprinting Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
6.1.5. Magnetic 3D bioprinting |
|
|
6.1.5.1. Magnetic 3D
bioprinting Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.5.2. Magnetic 3D
bioprinting Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.6. Other Technologies |
|
|
6.1.6.1. Other
Technologies Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.6.2. Other
Technologies Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
Chapter 7. 3D
Bioprinting Market, By Material Type (Market Size and Forecast by Value - USD
Million, 2017 - 2029) |
|
|
7.1. 3D Bioprinting Market, By Material
Type (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
7.1.1. Living Cells |
|
|
7.1.1.1. Living Cells Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
7.1.1.2. Living Cells Market Estimates and Forecast,
By Region, 2020-2030 (USD Million) |
|
|
7.1.2. Hydrogels |
|
|
7.1.2.1. Hydrogels Market Estimates and Forecast, 2020-2030
(USD Million) |
|
|
7.1.2.2. Hydrogels Market Estimates and Forecast,
By Region, 2020-2030 (USD Million) |
|
|
7.1.3. Extracellular Matrices |
|
|
7.1.3.1.
Extracellular Matrices Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
7.1.3.2. Extracellular Matrices Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
7.1.4. Other Biomaterials |
|
|
7.1.4.1. Other Biomaterials
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
7.1.4.2. Other
Biomaterials Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
|
Chapter 8. 3D
Bioprinting Market, By Application (Market Size and Forecast by Value - USD
Million, 2018 - 2028) |
|
|
8.1. 3D Bioprinting Market, By
Application (Market Size and Forecast by Value - USD Million, 2021 &
2028) |
|
|
8.1.1. Research applications |
|
|
8.1.1.1. Research applications Market Estimates and
Forecast, 2018-2028 (USD Million) |
|
|
8.1.1.2. Research applications Market Estimates and
Forecast, By Region, 2018-2028 (USD Million) |
|
|
8.1.2. Clinical applications |
|
|
8.1.2.1. Clinical applications Market Estimates and
Forecast, 2018-2028 (USD Million) |
|
|
8.1.2.2. Clinical applications Market Estimates and
Forecast, By Region, 2018-2028 (USD Million) |
|
|
Chapter 9. 3D
Bioprinting Market, By End user (Market Size and Forecast by Value - USD
Million, 2020 - 2030) |
|
|
9.1. 3D Bioprinting Market, By End user
(Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
9.1.1. Research Organizations
and Academic Institutes |
|
|
9.1.1.1. Research Organizations and Academic
Institutes Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.1.2. Research Organizations and Academic
Institutes Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
9.1.2. Biopharmaceutical
Companies |
|
|
9.1.2.1. Biopharmaceutical Companies Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.2.2. Biopharmaceutical Companies Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
9.1.3. Hospitals |
|
|
9.1.3.1. Hospitals
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
9.1.3.2. Hospitals
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
Chapter 10. 3D
Bioprinting Market, By Region (Market Size and Forecast by Value - USD
Million, 2020 - 2030) |
|
|
10.1. 3D Bioprinting Market, By Region
(Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
10.2. North America |
|
|
10.2.1. North America 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.2.2. North America 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.2.3. North America 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.2.4. North America 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.2.5. North America 3D
Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.2.6. North America 3D Bioprinting
Market, By Country, 2020-2030 (USD Million) |
|
|
10.2.7. U.S. |
|
|
10.2.7.1. U.S. 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.2.7.2. U.S. 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.2.7.3. U.S. 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.2.7.4. U.S. 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.2.7.5. U.S. 3D
Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.2.8. Canada |
|
|
10.2.8.1. Canada
3D Bioprinting Market, By Component Type, 2017-2029 (USD Million) |
|
|
10.2.8.2. Canada
3D Bioprinting Market, By Technology, 2017-2029 (USD Million) |
|
|
10.2.8.3. Canada 3D
Bioprinting Market, By Material Type, 2017-2029 (USD Million) |
|
|
10.2.8.4. Canada
3D Bioprinting Market, By Application, 2017-2029 (USD Million) |
|
|
10.2.8.5. Canada
3D Bioprinting Market, By End user, 2017-2029 (USD Million) |
|
|
10.3. Europe |
|
|
10.3.1. Europe 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.3.2. Europe 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.3. Europe 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.3.4. Europe3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.5. Europe3D Bioprinting
Market, By End user, 2020-2030 (USD Million) |
|
|
10.3.6. Europe 3D Bioprinting
Market, By Country, 2020-2030 (USD Million) |
|
|
10.3.7. Germany |
|
|
10.3.7.1. Germany
3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.3.7.2. Germany
3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.7.3. Germany
3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.3.7.4. Germany
3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.7.5. Germany
3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.3.8. U.K. |
|
|
10.3.8.1. U.K. 3D
Bioprinting Market, By Component Type, 2017-2029 (USD Million) |
|
|
10.3.8.2. U.K. 3D
Bioprinting Market, By Technology, 2017-2029 (USD Million) |
|
|
10.3.8.3. U.K. 3D
Bioprinting Market, By Material Type, 2017-2029 (USD Million) |
|
|
10.3.8.4. U.K. 3D
Bioprinting Market, By Application, 2017-2029 (USD Million) |
|
|
10.3.8.5. U.K. 3D
Bioprinting Market, By End user, 2017-2029 (USD Million) |
|
|
10.3.9. France |
|
|
10.3.9.1. France
3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.3.9.2. France
3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.9.3. France
3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.3.9.4. France 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.9.5. France
3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.3.10. Spain |
|
|
10.3.10.1. Spain 3D Bioprinting Market, By
Component Type, 2020-2030 (USD Million) |
|
|
10.3.10.2. Spain
3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.10.3. Spain
3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.3.10.4. Spain
3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.10.5. Spain
3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.3.11. Italy |
|
|
10.3.11.1. Italy
3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.3.11.2. Italy 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.11.3. Italy
3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.3.11.4. Italy
3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.11.5. Italy
3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.3.12. Rest of Europe |
|
|
10.3.12.1. Rest
of Europe 3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.3.12.2. Rest
of Europe 3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.3.12.3. Rest of
Europe 3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.3.12.4. Rest
of Europe 3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.3.12.5. Rest of
Europe 3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.4. Asia Pacific |
|
|
10.4.1. Asia Pacific 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.4.2. Asia Pacific 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.3. Asia Pacific 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.4.4. Asia Pacific 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.5. Asia Pacific 3D Bioprinting
Market, By End user, 2020-2030 (USD Million) |
|
|
10.4.6. Asia Pacific 3D
Bioprinting Market, By Country, 2020-2030 (USD Million) |
|
|
10.4.7. India |
|
|
10.4.7.1. India
3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.4.7.2. India
3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.7.3. India
3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.4.7.4. India
3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.7.5. India
3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.4.8. Japan |
|
|
10.4.8.1. Japan
3D Bioprinting Market, By Component Type, 2017-2029 (USD Million) |
|
|
10.4.8.2. Japan 3D
Bioprinting Market, By Technology, 2017-2029 (USD Million) |
|
|
10.4.8.3. Japan
3D Bioprinting Market, By Material Type, 2017-2029 (USD Million) |
|
|
10.4.8.4. Japan
3D Bioprinting Market, By Application, 2017-2029 (USD Million) |
|
|
10.5.8.5. Japan
3D Bioprinting Market, By End user, 2017-2029 (USD Million) |
|
|
10.4.9. China |
|
|
10.4.9.1. China
3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.4.9.2. China
3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.9.3. China 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.4.9.4. China
3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.10.5. China
3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.4.10. South Korea |
|
|
10.4.10.1. South
Korea 3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.4.10.2. South
Korea 3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.10.3. South
Korea 3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.4.10.4. South
Korea 3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.10.5. South
Korea 3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.4.11. Australia |
|
|
10.4.11.1. Australia
3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.4.11.2.
Australia 3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.11.3.
Australia 3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.4.11.4.
Australia 3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.11.5.
Australia 3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.4.12. Rest of Asia Pacific |
|
|
10.4.12.1. Rest
of Asia Pacific 3D Bioprinting Market, By Component Type, 2020-2030 (USD
Million) |
|
|
10.4.12.2. Rest
of Asia Pacific 3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.4.12.3. Rest
of Asia Pacific 3D Bioprinting Market, By Material Type, 2020-2030 (USD
Million) |
|
|
10.4.12.4. Rest of
Asia Pacific 3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.12.5. Rest
of Asia Pacific 3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.5. Middle East & Africa |
|
|
10.5.1. Middle East &
Africa 3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.5.2. Middle East &
Africa3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.5.3. Middle East & Africa
3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.5.4. Middle East &
Africa 3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.5. Middle East & Africa
3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.5.6. Middle East &
Africa 3D Bioprinting Market, By Country, 2020-2030 (USD Million) |
|
|
10.5.7. UAE |
|
|
10.5.7.1. UAE 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.5.7.2. UAE 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.5.7.3. UAE 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.5.7.4. UAE 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.7.5. UAE 3D
Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.5.8. Saudi Arabia |
|
|
10.5.8.1. Saudi
Arabia 3D Bioprinting Market, By Component Type, 2017-2029 (USD Million) |
|
|
10.5.8.2. Saudi
Arabia 3D Bioprinting Market, By Technology, 2017-2029 (USD Million) |
|
|
10.5.8.3. Saudi
Arabia 3D Bioprinting Market, By Material Type, 2017-2029 (USD Million) |
|
|
10.5.8.4. Saudi
Arabia 3D Bioprinting Market, By Application, 2017-2029 (USD Million) |
|
|
10.5.8.5. Saudi Arabia 3D Bioprinting
Market, By End user, 2017-2029 (USD Million) |
|
|
10.5.9. South Africa |
|
|
10.5.9.1. South
Africa 3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.5.9.2. South Africa 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.5.9.3. South Africa
3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.5.9.4. South
Africa 3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.5.9.5. South
Africa 3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.5.10. Rest of Middle East
& Africa |
|
|
10.5.10.1. Rest
of Middle East & Africa 3D Bioprinting Market, By Component Type, 2020-2030
(USD Million) |
|
|
10.5.10.2. Rest of Middle East &
Africa 3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.5.10.3. Rest
of Middle East & Africa 3D Bioprinting Market, By Material Type, 2020-2030
(USD Million) |
|
|
10.5.10.4. Rest of Middle
East & Africa 3D Bioprinting Market, By Application, 2020-2030 (USD
Million) |
|
|
10.5.10.5. Rest
of Middle East & Africa 3D Bioprinting Market, By End user, 2020-2030
(USD Million) |
|
|
10.6. Latin America |
|
|
10.6.1. Latin America 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.6.2. Latin America 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.6.3. Latin America 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.6.4. Latin America 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.6.5. Latin America 3D
Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.6.6. Latin America 3D
Bioprinting Market, By Country, 2020-2030 (USD Million) |
|
|
10.6.7. Brazil |
|
|
10.6.7.1. Brazil
3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.6.7.2. Brazil
3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.6.7.3. Brazil
3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.6.7.4. Brazil
3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.6.7.5. Brazil
3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.6.8. Mexico |
|
|
10.6.8.1. Mexico
3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.6.8.2. Mexico
3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.6.8.3. Mexico
3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.6.8.4. Mexico 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.6.8.5. Mexico
3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.6.9. Argentina |
|
|
10.6.9.1. Argentina
3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
|
10.6.9.2.
Argentina 3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.6.9.3.
Argentina 3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
|
10.6.9.4.
Argentina 3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.6.9.5. Argentina
3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
10.6.10. Rest of Latin America |
|
|
10.6.10.1. Rest
of Latin America 3D Bioprinting Market, By Component Type, 2020-2030 (USD
Million) |
|
|
10.6.10.2. Rest of Latin
America 3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
|
10.6.10.3. Rest
of Latin America 3D Bioprinting Market, By Material Type, 2020-2030 (USD
Million) |
|
|
10.6.10.4. Rest of Latin
America 3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
|
10.6.10.5. Rest
of Latin America 3D Bioprinting Market, By End user, 2020-2030 (USD Million) |
|
|
Chapter 11. Competitive Landscape |
|
|
11.1. Market Revenue Share by
Manufacturers |
|
|
11.2. Competitor’s Positioning |
|
|
11.3. Strategy Benchmarking |
|
|
11.3.1. Partnership &
Agreement |
|
|
11.3.2. New Product
Development |
|
|
11.3.3. Mergers & Acquisitions |
|
|
11.3.4. Investment &
Expansion |
|
|
11.4. Vendor Landscape |
|
|
11.4.1. Distributors |
|
|
11.4.2. North America |
|
|
11.4.3. Europe |
|
|
11.4.4. Asia Pacific |
|
|
11.4.5. Middle East &
Africa |
|
|
11.4.6. Latin America |
|
|
11.5. Zettabyte Analytics Insights for
Competitive Landscape |
|
|
Chapter 12. Company
Profiles |
|
|
12.1. 3Dbio Therapeutics |
|
|
12.1.1. Company Overview |
|
|
12.1.2. Products Offered |
|
|
12.1.3. Financials |
|
|
12.1.4. Recent
Development |
|
|
12.2. Advanced Solutions Life Sciences,
Llc |
|
|
12.2.1. Company Overview |
|
|
12.2.2. Products Offered |
|
|
12.2.3. Financials |
|
|
12.2.4. Recent
Development |
|
|
12.3. Allevi, Inc. (Part Of 3D Systems,
Inc.) |
|
|
12.3.1. Company Overview |
|
|
12.3.2. Products Offered |
|
|
12.3.3. Financials |
|
|
12.3.4. Recent
Development |
|
|
12.4. Aspect Biosystems Ltd. |
|
|
12.4.1. Company Overview |
|
|
12.4.2. Products Offered |
|
|
12.4.3. Financials |
|
|
12.4.4. Recent
Development |
|
|
12.5. Bico Group AB |
|
|
12.5.1. Company Overview |
|
|
12.5.2. Products Offered |
|
|
12.5.3. Financials |
|
|
12.5.4. Recent
Development |
|
|
12.6. Brinter |
|
|
12.6.1. Company Overview |
|
|
12.6.2. Products Offered |
|
|
12.6.3. Financials |
|
|
12.6.4. Recent Development |
|
|
12.7. Collplant Biotechnologies Ltd. |
|
|
12.7.1. Company Overview |
|
|
12.7.2. Products Offered |
|
|
12.7.3. Financials |
|
|
12.7.4. Recent
Development |
|
|
12.8. Cyfuse Biomedical K.K. |
|
|
12.8.1. Company Overview |
|
|
12.8.2. Products Offered |
|
|
12.8.3. Financials |
|
|
12.8.4. Recent
Development |
|
|
12.9. Envisiontec Gmbh (Part Of Desktop
Metal, Inc.) |
|
|
12.9.1. Company Overview |
|
|
12.9.2. Products Offered |
|
|
12.9.3. Financials |
|
|
12.9.4. Recent
Development |
|
|
12.10. Foldink Life Science Technologies |
|
|
12.10.1. Company Overview |
|
|
12.10.2. Products Offered |
|
|
12.10.3. Financials |
|
|
12.10.4. Recent
Development |
|
|
12.11. Gesim Mbh |
|
|
12.11.1. Company Overview |
|
|
12.11.2. Products Offered |
|
|
12.11.3. Financials |
|
|
12.11.4. Recent
Development |
|
|
12.12. Manchester Biogel |
|
|
12.12.1. Company Overview |
|
|
12.12.2. Products Offered |
|
|
12.12.3. Financials |
|
|
12.12.4. Recent
Development |
|
|
12.13. Organovo Holdings Inc. |
|
|
12.13.1. Company Overview |
|
|
12.13.2. Products Offered |
|
|
12.13.3. Financials |
|
|
12.13.4. Recent Development |
|
|
12.14. Pandorum Technologies Pvt. Ltd. |
|
|
12.14.1. Company Overview |
|
|
12.14.2. Products Offered |
|
|
12.14.3. Financials |
|
|
12.14.4. Recent
Development |
|
|
12.15. Poietis |
|
|
12.15.1. Company Overview |
|
|
12.15.2. Products Offered |
|
|
12.15.3. Financials |
|
|
12.15.4. Recent
Development |
|
|
12.16. Precise Bio |
|
|
12.16.1. Company Overview |
|
|
12.16.2. Products Offered |
|
|
12.16.3. Financials |
|
|
12.16.4. Recent
Development |
|
|
12.17. Prellis Biologics |
|
|
12.17.1. Company Overview |
|
|
12.17.2. Products Offered |
|
|
12.17.3. Financials |
|
|
12.17.4. Recent
Development |
|
|
12.18. Regemat 3D |
|
|
12.18.1. Company Overview |
|
|
12.18.2. Products Offered |
|
|
12.18.3. Financials |
|
|
12.18.4. Recent
Development |
|
|
12.19. Regenhu |
|
|
12.19.1. Company Overview |
|
|
12.19.2. Products Offered |
|
|
12.19.3. Financials |
|
|
12.19.4. Recent
Development |
|
|
12.20. Regenovo Biotechnology Co., Ltd.
(Part Of Shining 3D Tech Co., Ltd.) |
|
|
12.20.1. Company Overview |
|
|
12.20.2. Products Offered |
|
|
12.20.3. Financials |
|
|
12.20.4. Recent Development |
|
|
12.21. Revotek Co., Ltd. |
|
|
12.21.1. Company Overview |
|
|
12.21.2. Products Offered |
|
|
12.21.3. Financials |
|
|
12.21.4. Recent
Development |
|
|
12.22. Rokit Healthcare, Inc. |
|
|
12.22.1. Company Overview |
|
|
12.22.2. Products Offered |
|
|
12.22.3. Financials |
|
|
12.22.4. Recent
Development |
|
|
12.23. Sunp Biotech, Llc |
|
|
12.23.1. Company Overview |
|
|
12.23.2. Products Offered |
|
|
12.23.3. Financials |
|
|
12.23.4. Recent
Development |
|
|
12.24. Tissue Regeneration Systems Inc. |
|
|
12.24.1. Company Overview |
|
|
12.24.2. Products Offered |
|
|
12.24.3. Financials |
|
|
12.24.4. Recent
Development |
|
|
12.25. Vivax Bio, Llc |
|
|
12.25.1. Company Overview |
|
|
12.25.2. Products Offered |
|
|
12.25.3. Financials |
|
|
12.25.4. Recent
Development |
|
|
Chapter 12. Research
Methodology |
|
|
12.1. Research Sources |
|
|
12.1.1. Primary |
|
|
12.1.2. Secondary |
|
|
12.12. Market Size Estimation |
|
|
Chapter 13. Appendix |
|
|
13.1. Discussion guide |
|
|
13.2. Knowledge Store:
Zettabyte Analytics Subscription Portal |
|
|
13.3. Available
Customizations |
|
|
13.4. Associated
Zettabyte Analytics Reports |
|
|
List of Tables |
|
|
Table 1 |
3D Bioprinting Market, By
Component Type (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
Table 2 |
3D Bioprinters Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 3 |
3D Bioprinters Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 4 |
Bioinks Market Estimates
and Forecast, 2020-2030 (USD Million) |
|
Table 5 |
Bioinks Market Estimates
and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 6 |
3D Bioprinting Market, By
Technology (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
Table 7 |
Microextrusion
bioprinting Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 8 |
Microextrusion
bioprinting Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 9 |
3D Bioprinting Market, By
Material Type (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
Table 10 |
Living Cells Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 11 |
Living Cells Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 12 |
Hydrogels Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 13 |
Hydrogels Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 14 |
Extracellular Matrices
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 15 |
Extracellular Matrices
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 16 |
3D Bioprinting Market, By
Application (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
Table 17 |
Research applications
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 18 |
Research applications
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 19 |
Clinical applications
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 20 |
Clinical applications
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 21 |
North America 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 22 |
North America 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 23 |
North America 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
Table 24 |
North America 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 25 |
North America 3D
Bioprinting Market, By Country, 2020-2030 (USD Million) |
|
Table 26 |
U.S. 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 27 |
U.S. 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 28 |
U.S. 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 29 |
U.S. 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 30 |
Canada 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 31 |
Canada 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 32 |
Canada 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 33 |
Canada 3D Bioprinting Market,
By Application, 2020-2030 (USD Million) |
|
Table 34 |
Europe 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 35 |
Europe 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 36 |
Europe 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 37 |
Europe3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 38 |
Europe 3D Bioprinting
Market, By Country, 2020-2030 (USD Million) |
|
Table 39 |
Germany 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 40 |
Germany 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 41 |
Germany 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 42 |
Germany 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 43 |
U.K. 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 44 |
U.K. 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 45 |
U.K. 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 46 |
U.K. 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 47 |
France 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 48 |
France 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 49 |
France 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 50 |
France 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 51 |
Spain 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 52 |
Spain 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 53 |
Spain 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 54 |
Spain 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 55 |
Italy 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 56 |
Italy 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 57 |
Italy 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 58 |
Italy 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 59 |
Rest of Europe 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 60 |
Rest of Europe 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 61 |
Rest of Europe 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
Table 62 |
Rest of Europe 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 63 |
Asia Pacific 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 64 |
Asia Pacific 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 65 |
Asia Pacific 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
Table 66 |
Asia Pacific 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 67 |
Asia Pacific 3D
Bioprinting Market, By Country, 2020-2030 (USD Million) |
|
Table 68 |
India 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 69 |
India 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 70 |
India 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 71 |
India 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 72 |
Japan 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 73 |
Japan 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 74 |
Japan 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 75 |
Japan 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 76 |
China 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 77 |
China 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 78 |
China 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 79 |
China 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 80 |
South Korea 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 81 |
South Korea 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 82 |
South Korea 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
Table 83 |
South Korea 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 84 |
Australia 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 85 |
Australia 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 86 |
Australia 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 87 |
Australia 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 88 |
Rest of Asia Pacific 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 89 |
Rest of Asia Pacific 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 90 |
Rest of Asia Pacific 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
Table 91 |
Rest of Asia Pacific 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 92 |
Middle East & Africa
3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 93 |
Middle East &
Africa3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 94 |
Middle East & Africa
3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
Table 95 |
Middle East & Africa
3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 96 |
Middle East & Africa
3D Bioprinting Market, By Country, 2020-2030 (USD Million) |
|
Table 97 |
UAE 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 98 |
UAE 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 99 |
UAE 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 100 |
UAE 3D Bioprinting Market,
By Application, 2020-2030 (USD Million) |
|
Table 101 |
Saudi Arabia 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 102 |
Saudi Arabia 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 103 |
Saudi Arabia 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 104 |
Saudi Arabia 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 105 |
South Africa 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 106 |
South Africa 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 107 |
South Africa 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
Table 108 |
South Africa 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 109 |
Rest of Middle East &
Africa 3D Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 110 |
Rest of Middle East &
Africa 3D Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 111 |
Rest of Middle East &
Africa 3D Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
Table 112 |
Rest of Middle East &
Africa 3D Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 113 |
Latin America 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 114 |
Latin America 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 115 |
Latin America 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
Table 116 |
Latin America 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 117 |
Latin America 3D
Bioprinting Market, By Country, 2020-2030 (USD Million) |
|
Table 118 |
Brazil 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 119 |
Brazil 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 120 |
Brazil 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 121 |
Brazil 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 122 |
Mexico 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 123 |
Mexico 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 124 |
Mexico 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 125 |
Mexico 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 126 |
Argentina 3D Bioprinting
Market, By Component Type, 2020-2030 (USD Million) |
|
Table 127 |
Argentina 3D Bioprinting
Market, By Technology, 2020-2030 (USD Million) |
|
Table 128 |
Argentina 3D Bioprinting
Market, By Material Type, 2020-2030 (USD Million) |
|
Table 129 |
Argentina 3D Bioprinting
Market, By Application, 2020-2030 (USD Million) |
|
Table 130 |
Rest of Latin America 3D
Bioprinting Market, By Component Type, 2020-2030 (USD Million) |
|
Table 131 |
Rest of Latin America 3D
Bioprinting Market, By Technology, 2020-2030 (USD Million) |
|
Table 132 |
Rest of Latin America 3D
Bioprinting Market, By Material Type, 2020-2030 (USD Million) |
|
Table 133 |
Rest of Latin America 3D
Bioprinting Market, By Application, 2020-2030 (USD Million) |
|
Table 134 |
Product Launch &
Development in The 3D Bioprinting Market, 2020-2022 |
|
Table 135 |
Investment and Expansion
in The 3D Bioprinting Market, 2020-2022 |
|
Table 136 |
Partnership &
Collaboration in The 3D Bioprinting Market, 2020-2022 |
|
Table 137 |
Merger & Acquisition
in The 3D Bioprinting Market, 2020-2022 |
|
List of Figures |
|
|
Figure 1 |
Research Methodology |
|
Figure 2 |
Summary Snapshot Market
Size and Forecast, USD Million, 2022 & 2030 |
|
Figure 3 |
Global 3D Bioprinting
Market Segmentation & Impact Analysis |
|
Figure 4 |
Regulatory Analysis |
|
Figure 5 |
COVID-19 Impact analysis
on 3D Bioprinting Market |
|
Figure 6 |
Market Revenue Share by
Manufacturers |
|
Figure 7 |
3D Bioprinting Market, By
Component Type (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
Figure 8 |
3D Bioprinting Market, By
Technology (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
Figure 9 |
3D Bioprinting Market, By
Material Type (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
Figure 10 |
3D Bioprinting Market, By
Application (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
Figure 11 |
3D Bioprinting Market, By
Region (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States